Complex therapy in fulminant course of acute viral hepatitis В and В + D

Abstract

The present article considers modern pathogenetic approach to treatment of patients with fulminant course of acute viral hepatitis B and B + D. Results of complex treatment of patients with acute viral hepatitis B and B + D against the background of use of antiviral drug lamivudine are presented. Prognosis of disease greatly improved due to this therapeutic regimen. These findings demonstrate the need for the administration of antiviral therapy in this category of patients regardless of the time of their admission to hospital.

References

  1. Poland GA, Jacobson RM. Clinical practice: prevention of hepatitis B with the hepatitis vaccine. N Engl J Med 2004;351:2832-38.
  2. Шерлок Ш., Дули Дж. Заболевания печени и желчных путей / Под ред. З.Г. Апросиной, Н.А. Мухина. М.: ГЕОТАР Медицина, 1999. 864 с.
  3. Conn HO, Bircher J. Hepatic encephalopathy: syndromes and therapies. Bloomington. Illinois: Medi Ed Press, 1994;243.
  4. Fitz GJ. Hepatic Encephalopathy, Hepatopulmonary Syndromes, Hepatorenal Syndrome, Coagulopathy, and Endocrine Complications of Liver Disease. Feldman: Sleisenger & Fordtran's Gastrointestinal and Liver Disease, 7th ed. 2002;1543-49.
  5. Ивашкин В.Т. Болезни печени и желчевыводящих путей: Руководство для врачей. М., Вести, 2002. 416 с.
  6. Цодиков Г.В., Богомолов П.О. Печеночная энцефалопатия: патофизиологические основы терапии // РМЖ. Болезни органов пищеварения. 2003. № 5. С.76-80.
  7. Miyake Y, Iwasaki Y, Takaki A, et al. Lamivudine treatment improves the prognosis of fulminant hepatitis B Intern Med 2008;47(14):1293-9.
  8. Wang Y-M, Tang Y-Z. Antiviral therapy for hepatitis B virus associated hepatic failure. Hepatobil Pancreat Dis Int 2009;8(1):17-24.
  9. http://www.pharmateca.ru/cgi-bin/statyi.pl?sid=2536&mid=1085056570&magid=188

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies